Mapping of brain macromolecules and their use for spectral processing of 1H-MRSI data with an ultra-short acquisition delay at 7T

Long echo time (TE) MR spectroscopy (MRS) sequences are sensitive only to metabolites of low molecular weight. At shorter TE, significantly more metabolite signals are detectable, including broad signals of high-molecular-weight macromolecules (MMs). Although the presence of MM resonances can bias metabolite quantification at short TE, proper quantification of MMs is important since MMs themselves may serve as potentially valuable biomarkers for many pathologies. We have therefore developed an FID-based 2D-MR Spectroscopic Imaging (2D-MRSI) sequence to map MMs in healthy brain tissue at 7 T within a scan time of ~17 min and a repetition time of 879 ms. This 2D-MRSI technique provides MM maps over a whole slice (i.e., including cortical gray matter) at an ultra-short acquisition delay of 1.3 ms, using double inversion for efficient nulling of low-molecular-weight metabolites. The optimal sequence parameters were estimated using Bloch simulations, phantom testing, and in vivo validation. The acquired in vivo MM spectra (n=6) included nine distinct MM peaks in the range of ~0.9-3.7 ppm. The measured average MM spectrum was incorporated into the LCModel basis set and utilized for further quantification of MRSI data sets without metabolite nulling, which were acquired in five additional volunteers. The quantification results for two basis sets, one including the MMs and one without MM spectrum, were compared. Due to the high spectral resolution and full signal detection provided by the FID-MRSI sequence, we could successfully map five important brain metabolites. Most quantified metabolite signal amplitudes were significantly lower since the inclusion of MMs into the basis set corrected the overestimation of metabolite signals. The precision of fit (i.e., Cramér Rao lower bounds) remained unchanged. Our MM maps show that the overall MM contribution was higher in gray matter than in white matter. In conclusion, the acquired MM spectrum improved the accuracy of metabolite quantification and allowed the acquisition of high spatial resolution maps of five major brain metabolites and also MMs.

[1]  L O Hall,et al.  Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging , 2006, NMR in biomedicine.

[2]  M. Chmelika,et al.  Coil combination of multichannel MRSI data at 7 T: MUSICAL , 2013 .

[3]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[4]  Terence W Nixon,et al.  High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo , 2006, Magnetic resonance in medicine.

[5]  Michael Erb,et al.  Proton magnetic resonance spectroscopy with metabolite nulling reveals regional differences of macromolecules in normal human brain , 2002, Journal of magnetic resonance imaging : JMRI.

[6]  Martijn P. van den Heuvel,et al.  Glutamate changes in healthy young adulthood , 2013, European Neuropsychopharmacology.

[7]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[8]  M. Pomper,et al.  Quantitative proton magnetic resonance spectroscopic imaging: Regional variations in the corpus callosum and cortical gray matter , 2005, Journal of magnetic resonance imaging : JMRI.

[9]  Rolf Gruetter,et al.  Proton T2 relaxation time of J‐coupled cerebral metabolites in rat brain at 9.4 T , 2008, NMR in biomedicine.

[10]  Tobias Kober,et al.  MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.

[11]  Wolfgang Bogner,et al.  3D GABA imaging with real-time motion correction, shim update and reacquisition of adiabatic spiral MRSI , 2014, NeuroImage.

[12]  Rolf Gruetter,et al.  Is the macromolecule signal tissue‐specific in healthy human brain? A 1H MRS study at 7 tesla in the occipital lobe , 2014, Magnetic resonance in medicine.

[13]  Peter B Barker,et al.  Comparison of brain gray and white matter macromolecule resonances at 3 and 7 Tesla , 2015, Magnetic resonance in medicine.

[14]  Peter R Luijten,et al.  Multislice 1H MRSI of the human brain at 7 T using dynamic B0 and B1 shimming , 2012, Magnetic resonance in medicine.

[15]  R. B. Kingsley,et al.  WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. , 1994, Journal of magnetic resonance. Series B.

[16]  E G Tangalos,et al.  1H MR spectroscopy in common dementias , 2004, Neurology.

[17]  S. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[18]  F. Howe,et al.  Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.

[19]  Jeff H Duyn,et al.  Sphere of lorentz and demagnetization factors in white matter , 2014, Magnetic resonance in medicine.

[20]  Mohammad Sabati,et al.  Comparison of a short-TE whole brain MR spectroscopic imaging to single voxel spectroscopy for measurement of metabolite concentrations in human brain , 2013 .

[21]  Rolf Gruetter,et al.  Proton T2 relaxation time of J‐coupled cerebral metabolites in rat brain at 9.4 T , 2008, NMR in biomedicine.

[22]  Rolf Gruetter,et al.  Quantification of in vivo short echo-time proton magnetic resonance spectra at 14.1 T using two different approaches of modelling the macromolecule spectrum , 2009 .

[23]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[24]  Rolf Gruetter,et al.  In vivo metabolic profiling of glioma‐initiating cells using proton magnetic resonance spectroscopy at 14.1 Tesla , 2012, NMR in biomedicine.

[25]  Michael Schär,et al.  Magnetic resonance Spectroscopy with Linear Algebraic Modeling (SLAM) for higher speed and sensitivity. , 2012, Journal of magnetic resonance.

[26]  D. Saunders,et al.  Discrimination of Metabolite from Lipid and Macromolecule Resonances in Cerebral Infarction in Humans Using Short Echo Proton Spectroscopy , 1997, Journal of magnetic resonance imaging : JMRI.

[27]  Rolf Gruetter,et al.  In vivo brain macromolecule signals in healthy and glioblastoma mouse models: 1H magnetic resonance spectroscopy, post‐processing and metabolite quantification at 14.1 T , 2014, Journal of neurochemistry.

[28]  Rolf Gruetter,et al.  Handling macromolecule signals in the quantification of the neurochemical profile. , 2012, Journal of Alzheimer's disease : JAD.

[29]  S. Aoki,et al.  Magnetic resonance , 2012, International Journal of Computer Assisted Radiology and Surgery.

[30]  R Lufkin,et al.  Localized two‐dimensional shift correlated MR spectroscopy of human brain , 2001, Magnetic resonance in medicine.

[31]  U. Klose,et al.  Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.

[32]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[33]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[34]  K Ugurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at 7 T , 2001, Magnetic resonance in medicine.

[35]  K. Behar,et al.  Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain , 1996, Magnetic resonance in medicine.

[36]  V. L. Doyle,et al.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.

[37]  Gülin Öz,et al.  Regional neurochemical profiles in the human brain measured by 1H MRS at 7 T using local B1 shimming , 2012, NMR in biomedicine.

[38]  Priti Balchandani,et al.  Fat suppression for 1H MRSI at 7T using spectrally selective adiabatic inversion recovery , 2008, Magnetic resonance in medicine.

[39]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[40]  Takashi Ogino,et al.  Characterization of macromolecule resonances in the 1H NMR spectrum of rat brain , 1993, Magnetic resonance in medicine.

[41]  P. Luijten,et al.  Direct B0 field monitoring and real‐time B0 field updating in the human breast at 7 tesla , 2012, Magnetic resonance in medicine.

[42]  Rolf Gruetter,et al.  Proton T1 relaxation times of metabolites in human occipital white and gray matter at 7 T , 2013, Magnetic resonance in medicine.

[43]  Chia-Ying Liu,et al.  Heterogeneous distribution of myocardial steatosis—An ex vivo evaluation , 2012, Magnetic resonance in medicine.

[44]  F Träber,et al.  A multicenter 1H-MRS study of the medial temporal lobe in AD and MCI , 2009, Neurology.

[45]  Rolf Gruetter,et al.  Quantification of the neurochemical profile using simulated macromolecule resonances at 3 T , 2013, NMR in biomedicine.

[46]  L. Axel,et al.  Rapid B1+ mapping using a preconditioning RF pulse with TurboFLASH readout , 2010, Magnetic resonance in medicine.

[47]  D L Rothman,et al.  Spectroscopic Assessment of Alterations in Macromolecule and Small-Molecule Metabolites in Human Brain After Stroke , 2001, Stroke.

[48]  R Gruetter,et al.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. , 1999, Journal of magnetic resonance.

[49]  Wolfgang Grodd,et al.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.

[50]  David Bonekamp,et al.  Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 Tesla , 2008, Journal of magnetic resonance imaging : JMRI.

[51]  W. Bogner,et al.  High‐resolution mapping of human brain metabolites by free induction decay 1H MRSI at 7 T , 2012, NMR in Biomedicine.

[52]  C Boesch,et al.  Characterization of the macromolecule baseline in localized 1H‐MR spectra of human brain , 2001, Magnetic resonance in medicine.

[53]  Peter Boesiger,et al.  Slice‐selective FID acquisition, localized by outer volume suppression (FIDLOVS) for 1H‐MRSI of the human brain at 7 T with minimal signal loss , 2009, NMR in biomedicine.

[54]  Robert Bartha,et al.  Semi‐LASER 1H MR spectroscopy at 7 Tesla in human brain: Metabolite quantification incorporating subject‐specific macromolecule removal , 2015, Magnetic resonance in medicine.

[55]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[56]  U Klose,et al.  Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.

[57]  J. Knight‐Scott,et al.  Application of multiple inversion recovery for suppression of macromolecule resonances in short echo time (1)H NMR spectroscopy of human brain. , 1999, Journal of magnetic resonance.

[58]  U Klose,et al.  Mapping of the radio frequency magnetic field with a MR snapshot FLASH technique. , 1992, Medical physics.